Tag Archives: First

FiercePharmaAsia—Japan’s global first nods; Celgene hands back PD-1; China’s copycat invite

Japan’s health ministry has sent out global first nods to drugs from Roche, Daiichi Sankyo and AstraZeneca. Two years after penning the licensing deal, Celgene has returned PD-1 tislelizumab to BeiGene along with a $ 150 million breakup fee. Multinational biopharma companies’ older medicines in China are under threat as authorities have made a list of 34… Read More »

First Edition: April 17, 2019

Today’s early morning highlights from the major news organizations. Kaiser Health News: Planned Parenthood’s ‘Risky Strategy’ To Update Its Image The Trump administration is pushing ahead with its reproductive health agenda. It has rolled out changes to the Title X program, which funds family planning services for low-income people, that are designed to have a… Read More »